• Title of article

    p63 is more sensitive and specific than 34βE12 to differentiate adenocarcinoma of prostate from cancer mimickers

  • Author/Authors

    -، - نويسنده Kidney Transplantation Complications Research Center, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Kalantari, Mahmoud Reza , -، - نويسنده Solid Tumor Treatment Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Anvari, Kazem , -، - نويسنده Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Jabbari, Hasan , -، - نويسنده Solid Tumor Treatment Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Varshoee Tabrizi, Fatemeh

  • Issue Information
    فصلنامه با شماره پیاپی 0 سال 2014
  • Pages
    5
  • From page
    497
  • To page
    501
  • Abstract
    -
  • Abstract
    Objective(s): Prostate cancer is the world’s leading cause of cancer and the second cause of cancer-related death in men after lung cancer. Differentiation of prostate adenocarcinoma from benign prostate lesions and hyperplasia sometimes cannot be done on the basis of morphologic findings. Considering the fact that in the prostate adenocarcinoma there is no basal cell layer, basal cell markers can help to differentiate prostate adenocarcinoma from cancer mimickers. Materials and Methods:We studied 98 prostate biopsy blocks (40 adenocarcinoma and 58 benign lesions) for basal cell marker expression. Results: p63 and 34βE12 were negative in all prostate adenocarcinoma specimens, but all benign prostate hyperplasia and high grade intraepithelial neoplasia cases expressed them. Conclusion: Basal cell markers can help to distinguish prostate adenocarcinoma from cancer mimickers.
  • Journal title
    Iranian Journal of Basic Medical Sciences
  • Serial Year
    2014
  • Journal title
    Iranian Journal of Basic Medical Sciences
  • Record number

    2258908